| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/21/2013 | CA2843084A1 Anthranilamide compounds and their use as pesticides |
| 02/21/2013 | CA2843083A1 Anthranilamide compounds and their use as pesticides |
| 02/21/2013 | CA2842858A1 N-thio-anthranilamide compounds and their use as pesticides |
| 02/21/2013 | CA2842857A1 Aniline type compounds |
| 02/21/2013 | CA2841801A1 Inhibitors of bruton's tyrosine kinase |
| 02/20/2013 | EP2559687A1 Mesoionic pesticides |
| 02/20/2013 | EP2559686A1 Therapeutic quinoline and naphthalene derivatives |
| 02/20/2013 | EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors |
| 02/20/2013 | EP2558460A1 Triazole-substituted anthranilic acid amides as pesticides |
| 02/20/2013 | EP2558459A1 Phthalazin-(2h)-one inhibitors of kinases |
| 02/20/2013 | EP2558458A2 Novel heterocyclic compounds as pest control agents |
| 02/20/2013 | EP2558457A1 Arylethynyl derivatives |
| 02/20/2013 | EP2558449A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 02/20/2013 | EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | EP2558094A1 Pyridone derivatives |
| 02/20/2013 | CN102939288A Process for the preparation of dihydropyrrole derivatives |
| 02/20/2013 | CN102939284A Agent for treating hcv infection |
| 02/20/2013 | CN102939283A Indazole compounds useful as ketohexokinase inhibitors |
| 02/20/2013 | CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936239A Organic ligand, metal organic frames based on Cu (I) ions, synthetic method for organic ligand and metal organic frames based on Cu (I) ions and application |
| 02/20/2013 | CN102936238A New crystal form of S-omeprazole magnesium salt and preparation method thereof |
| 02/20/2013 | CN102936221A 桥联环状胺化合物以及有害生物防除剂 Bridged cyclic amine compound and a pest control agent |
| 02/20/2013 | CN102935510A Preparation and catalysis for stable water-soluble palladium nano particles of ionic nitrogen-containing ligand |
| 02/20/2013 | CN102161656B Aspartic acid-specific caspase inhibitors and uses thereof |
| 02/20/2013 | CN101959427B Flavor molecules |
| 02/20/2013 | CN101595094B Cycloalkylamine substituted isoquinolone derivatives |
| 02/19/2013 | US8378111 Process for the resolution of (R,S)-nicotine |
| 02/19/2013 | US8378110 Process for the preparation of (R, S)-nicotine |
| 02/19/2013 | US8378109 Labeled ALPHA4BETA2 ligands and methods therefor |
| 02/19/2013 | US8378108 Apoptosis signal-regulating kinase inhibitors |
| 02/19/2013 | US8378105 Crystalline pharmaceutical and methods of preparation and use thereof |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8378096 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 02/19/2013 | US8378095 Oxazole tyrosine kinase inhibitors |
| 02/19/2013 | US8377971 Non-flushing niacin analogues, and methods of use thereof |
| 02/19/2013 | US8377970 Modulators of calcium release-activated calcium channel |
| 02/19/2013 | US8377966 Biphenyl compounds useful as muscarinic receptor antagonists |
| 02/19/2013 | US8377961 Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53 |
| 02/19/2013 | US8377954 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
| 02/19/2013 | US8377953 Isothiazole and pyrazole derivatives as fungicides |
| 02/19/2013 | US8377938 Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same |
| 02/19/2013 | US8377932 Preparation of 1-(substituted benzyl)-5-trifluoromethyl-2(1H)pyridone compounds and salts thereof and their applications |
| 02/19/2013 | US8377924 Protein kinase C inhibitors and uses thereof |
| 02/19/2013 | US8377192 Stabilisers for inanimate organic materials |
| 02/19/2013 | CA2616513C Benzylpiperazine derivates useful for the treatment of gastrointestinal disorders |
| 02/19/2013 | CA2588148C 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof |
| 02/19/2013 | CA2573371C Pyrimidines as plk inhibitors |
| 02/19/2013 | CA2569716C Hydantoin derivatives for the treatment of obstructive airway diseases |
| 02/19/2013 | CA2568808C Chemical compounds |
| 02/19/2013 | CA2562780C Nucleic acid melting analysis with saturation dyes |
| 02/19/2013 | CA2560256C Heteroaryl piperidine glycine transporter inhibitors |
| 02/19/2013 | CA2508657C Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2409044C Improved recrystallization processes for obtaining anhydrous optically active lansoprazole |
| 02/14/2013 | WO2013021398A2 A process for preparation of mivacurium chloride |
| 02/14/2013 | WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 02/14/2013 | WO2013021021A1 Novel soft pde4 inhibitors |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020370A1 Pim kinase inhibitor and preparation method and use in medicinal manufacture thereof |
| 02/14/2013 | WO2012025237A9 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators |
| 02/14/2013 | US20130041149 New Method for Synthesizing Imatinib |
| 02/14/2013 | US20130041148 Process for the synthesis of n-alkoxyamines |
| 02/14/2013 | US20130041046 Sweet flavor modifier |
| 02/14/2013 | US20130040995 Novel compounds |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040989 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 02/14/2013 | US20130040983 Raf kinase inhibitors |
| 02/14/2013 | US20130040977 Pro-Neurogenic Compounds |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040961 Oligomer modified diaromatic substituted compounds |
| 02/14/2013 | US20130040958 Imatinib mesylate preparation procedure |
| 02/14/2013 | US20130040951 Prophylactic or therapeutic agent for cancer |
| 02/14/2013 | US20130040950 Multisubstituted aromatic compounds as inhibitors of thrombin |
| 02/14/2013 | US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/14/2013 | US20130040941 Benzodiazepine compound and pharmaceutical composition |
| 02/14/2013 | US20130040930 Novel amide derivative and use thereof as medicine |
| 02/14/2013 | US20130040929 Novel prolylcarboxypeptidase inhibitors |
| 02/14/2013 | US20130040907 Compounds, Compositions and Methods of Using Same for Modulating Uric Acid Levels |
| 02/14/2013 | US20130040359 Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition |
| 02/14/2013 | US20130039989 Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide |
| 02/14/2013 | US20130039929 Method treating breast cancer |
| 02/14/2013 | US20130038515 Novel organic compound and organic light-emitting device including the same |
| 02/14/2013 | CA2844852A1 Pim kinase inhibitors and preparation methods and use in medicinal manufacture thereof |
| 02/14/2013 | CA2842853A1 Novel soft pde4 inhibitors |
| 02/13/2013 | EP2556081A2 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation |
| 02/13/2013 | EP2556069A1 Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators |
| 02/13/2013 | EP2556068A1 P38 map kinase inhibitors |
| 02/13/2013 | EP2556067A2 Pyrazolyl ureas as p38 map kinase inhibitors |
| 02/13/2013 | EP2556066A1 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 02/13/2013 | EP2556065A1 Pyrazole p38 map kinase inhibitors |
| 02/13/2013 | EP2556064A2 Process for the preparation of 2-(cyclohexylmethyl)-n-{2- [(2s)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4- tetrahydroisoquinoline-7-sulfonamide |
| 02/13/2013 | EP2556063A1 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 02/13/2013 | EP2556057A1 7,11-methanocycloocta [b]quinoline derivative as highly functionalizable acetylcholinesterase inhibitors |
| 02/13/2013 | EP2556056A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 02/13/2013 | EP2555617A1 Novel hypoglycemic compounds |
| 02/13/2013 | CN102933576A Pyrimidinylpiperidinyloxypyridinone analogues as gpr119 modulators |
| 02/13/2013 | CN102933575A Yclohexyl-azetidinyl antagonists of ccr2 |
| 02/13/2013 | CN102933573A Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof |
| 02/13/2013 | CN102933572A Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |